Literature DB >> 19473886

Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response.

Travis H Stracker1, Takehiko Usui, John H J Petrini.   

Abstract

The cellular DNA damage response (DDR) is activated by many types of DNA lesions. Upon recognition of DNA damage by sensor proteins, an intricate signal transduction network is activated to coordinate diverse cellular outcomes that promote genome integrity. Key components of the DDR in mammalian cells are the checkpoint effector kinases Chk1 and Chk2 (referred to henceforth as the effector kinases; orthologous to spChk1 and spCds1 in the fission yeast S. pombe and scChk1 and scRad53 in the budding yeast S. cerevisiae). These evolutionarily conserved and structurally divergent kinases phosphorylate numerous substrates to regulate the DDR. This review will focus on recent advances in our understanding of the structure, regulation, and functions of the effector kinases in the DDR, as well as their potential roles in human disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19473886      PMCID: PMC2725228          DOI: 10.1016/j.dnarep.2009.04.012

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  135 in total

1.  Regulation of Chk1 kinase by autoinhibition and ATR-mediated phosphorylation.

Authors:  Yoshinori Katsuragi; Noriyuki Sagata
Journal:  Mol Biol Cell       Date:  2004-02-06       Impact factor: 4.138

2.  Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2.

Authors:  Harry A Rogoff; Mary T Pickering; Fiona M Frame; Michelle E Debatis; Yolanda Sanchez; Stephen Jones; Timothy F Kowalik
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 3.  Targeting the checkpoint kinases: chemosensitization versus chemoprotection.

Authors:  Bin-Bing S Zhou; Jiri Bartek
Journal:  Nat Rev Cancer       Date:  2004-03       Impact factor: 60.716

4.  The DNA replication checkpoint directly regulates MBF-dependent G1/S transcription.

Authors:  Chaitali Dutta; Prasanta K Patel; Adam Rosebrock; Anna Oliva; Janet Leatherwood; Nicholas Rhind
Journal:  Mol Cell Biol       Date:  2008-07-28       Impact factor: 4.272

5.  Activation of ATR and related PIKKs.

Authors:  Daniel A Mordes; David Cortez
Journal:  Cell Cycle       Date:  2008-09-30       Impact factor: 4.534

6.  Collaboration of Brca1 and Chk2 in tumorigenesis.

Authors:  John Peter McPherson; Bénédicte Lemmers; Atsushi Hirao; Anne Hakem; Jacinth Abraham; Eva Migon; Elzbieta Matysiak-Zablocki; Laura Tamblyn; Otto Sanchez-Sweatman; Rama Khokha; Jeremy Squire; M Prakash Hande; Tak W Mak; Razqallah Hakem
Journal:  Genes Dev       Date:  2004-05-06       Impact factor: 11.361

7.  Chk1 is haploinsufficient for multiple functions critical to tumor suppression.

Authors:  Michael H Lam; Qinghua Liu; Stephen J Elledge; Jeffrey M Rosen
Journal:  Cancer Cell       Date:  2004-07       Impact factor: 31.743

8.  Recovery from DNA damage checkpoint arrest by PP1-mediated inhibition of Chk1.

Authors:  Nicole R den Elzen; Matthew J O'Connell
Journal:  EMBO J       Date:  2004-02-05       Impact factor: 11.598

9.  Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway.

Authors:  Dmitry V Bulavin; Crissy Phillips; Bonnie Nannenga; Oleg Timofeev; Larry A Donehower; Carl W Anderson; Ettore Appella; Albert J Fornace
Journal:  Nat Genet       Date:  2004-02-29       Impact factor: 38.330

10.  Regulation of Chk2 ubiquitination and signaling through autophosphorylation of serine 379.

Authors:  Christine M Lovly; Ling Yan; Christine E Ryan; Saeko Takada; Helen Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2008-07-21       Impact factor: 4.272

View more
  114 in total

1.  Alisertib (MLN8237), a selective Aurora-A kinase inhibitor, induces apoptosis in human tongue squamous cell carcinoma cell both in vitro and in vivo.

Authors:  Lin Qi; Yang Zhang
Journal:  Tumour Biol       Date:  2014-11-04

Review 2.  Evolution of networks and sequences in eukaryotic cell cycle control.

Authors:  Frederick R Cross; Nicolas E Buchler; Jan M Skotheim
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-12-27       Impact factor: 6.237

Review 3.  The role of post-translational modifications in fine-tuning BLM helicase function during DNA repair.

Authors:  Stefanie Böhm; Kara Anne Bernstein
Journal:  DNA Repair (Amst)       Date:  2014-08-24

4.  Phosphorylation at threonine 288 by cell cycle checkpoint kinase 2 (CHK2) controls human monopolar spindle 1 (Mps1) kinetochore localization.

Authors:  Chun-Wei Yeh; Zheng-Cheng Yu; Peng-Hsu Chen; Yu-Che Cheng; Sheau-Yann Shieh
Journal:  J Biol Chem       Date:  2014-04-24       Impact factor: 5.157

5.  Time-course analysis of DNA damage response-related genes after in vitro radiation in H460 and H1229 lung cancer cell lines.

Authors:  Kang Ho Kim; Hae Yong Yoo; Kyeung Min Joo; Yong Jung; Juyoun Jin; Yonghyun Kim; Su Jin Yoon; Seung Ho Choi; Ho Jun Seol; Woong Yang Park; Do Hyun Nam
Journal:  Exp Mol Med       Date:  2011-07-30       Impact factor: 8.718

Review 6.  The regulation of the p53-mediated stress response by MDM2 and MDM4.

Authors:  Mary Ellen Perry
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-01       Impact factor: 10.005

7.  VIP blockade leads to microcephaly in mice via disruption of Mcph1-Chk1 signaling.

Authors:  Sandrine Passemard; Vincent El Ghouzzi; Hala Nasser; Catherine Verney; Guilan Vodjdani; Adrien Lacaud; Sophie Lebon; Marc Laburthe; Patrick Robberecht; Jeannette Nardelli; Shyamala Mani; Alain Verloes; Pierre Gressens; Vincent Lelièvre
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

8.  Regulation of zygotic genome activation and DNA damage checkpoint acquisition at the mid-blastula transition.

Authors:  Maomao Zhang; Priyanka Kothari; Mary Mullins; Michael A Lampson
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  Checkpoint kinase 2 is required for efficient immunoglobulin diversification.

Authors:  Kathrin Davari; Samantha Frankenberger; Angelika Schmidt; Nils-Sebastian Tomi; Berit Jungnickel
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 10.  Roles of Chk1 in cell biology and cancer therapy.

Authors:  Youwei Zhang; Tony Hunter
Journal:  Int J Cancer       Date:  2013-05-28       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.